Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Dextenza Versus Topical Steroid Eye Drops for Postoperative Management Following Corneal Crosslinking [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing Dextenza to topical steroid eye drops for post-operative management after corneal crosslinking in keratoconus is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)

Snippet

Sponsor: Maanasa Indaram, MD | Conditions: Keratoconus | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION